Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia

Dimitrios Papaioannou, Deedra Nicolet, Stefano Volinia, Krzysztof Mrózek, Pearlly Yan, Ralf Bundschuh, Andrew J. Carroll, Jessica Kohlschmidt, William Blum, Bayard L. Powell, Geoffrey L. Uy, Jonathan E. Kolitz, Eunice S. Wang, Ann Kathrin Eisfeld, Shelley J. Orwick, David M. Lucas, Michael A. Caligiuri, Richard M. Stone, John C. Byrd, Ramiro GarzonClara D. Bloomfield

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Long non-coding ribonucleic acids (RNAs) are a novel class of RNA molecules, which are increasingly recognized as important molecular players in solid and hematologic malignancies. Herein we investigated whether long non-coding RNA expression is associated with clinical and molecular features, as well as outcome of younger adults (aged <60 years) with de novo cytogenetically normal acute myeloid leukemia. Whole transcriptome profiling was performed in a training (n=263) and a validation set (n=114). Using the training set, we identified 24 long non-coding RNAs associated with event-free survival. Linear combination of the weighted expression values of these transcripts yielded a prognostic score. In the validation set, patients with high scores had shorter disease-free (P<0.001), overall (P=0.002) and event-free survival (P<0.001) than patients with low scores. In multivariable analyses, long non-coding RNA score status was an independent prognostic marker for disease-free (P=0.01) and event-free survival (P=0.002), and showed a trend for overall survival (P=0.06). Among multiple molecular alterations tested, which are prognostic in cytogenetically normal acute myeloid leukemia, only double CEBPA mutations, NPM1 mutations and FLT3-ITD associated with distinct long non-coding RNA signatures. Correlation of the long non-coding RNA scores with messenger RNA and microRNA expression identified enrichment of genes involved in lymphocyte/leukocyte activation, inflammation and apoptosis in patients with high scores. We conclude that long non-coding RNA profiling provides meaningful prognostic information in younger adults with cytogenetically normal acute myeloid leukemia. In addition, expression of prognostic long non-coding RNAs associates with oncogenic molecular pathways in this disease. clinicaltrials.gov Identifier: 00048958 (CALGB-8461), 00899223 (CALGB-9665), and 00900224 (CALGB-20202).

Original languageEnglish
Pages (from-to)1391-1400
Number of pages10
JournalHaematologica
Volume102
Issue number8
DOIs
StatePublished - Jul 31 2017

Fingerprint Dive into the research topics of 'Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia'. Together they form a unique fingerprint.

  • Cite this

    Papaioannou, D., Nicolet, D., Volinia, S., Mrózek, K., Yan, P., Bundschuh, R., Carroll, A. J., Kohlschmidt, J., Blum, W., Powell, B. L., Uy, G. L., Kolitz, J. E., Wang, E. S., Eisfeld, A. K., Orwick, S. J., Lucas, D. M., Caligiuri, M. A., Stone, R. M., Byrd, J. C., ... Bloomfield, C. D. (2017). Prognostic and biologic significance of long non-coding RNA profiling in younger adults with cytogenetically normal acute myeloid leukemia. Haematologica, 102(8), 1391-1400. https://doi.org/10.3324/haematol.2017.166215